Product Code: MCP-7645
Amid the COVID-19 crisis and the looming economic recession, the Biomarkers market worldwide will grow by a projected US$60.2 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 12.9%. Safety, one of the segments analyzed and sized in this study, is forecast to grow at over 12.5% and reach a market size of US$44.4 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Safety market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 11.2% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$2.2 Billion to the region's size over the next 7 to 8 years. In addition, over US$1.9 Billion worth of projected demand in the region will come from Rest of European markets. In Japan, the Safety segment will reach a market size of US$1.9 Billion by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Biomarkers market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 17.8% over the next couple of years and add approximately US$11.9 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Biomarkers market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others, Abbott Molecular, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Epigenomics AG; F. Hoffmann-La Roche AG; Johnson & Johnson; QIAGEN NV; Siemens Healthineers; Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Biomarkers Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: Biomarkers Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 2: Biomarkers Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
- TABLE 3: Biomarkers Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
- TABLE 4: Safety (Type) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 5: Safety (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
- TABLE 6: Safety (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
- TABLE 7: Efficacy (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
- TABLE 8: Efficacy (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
- TABLE 9: Efficacy (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
- TABLE 10: Validation (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
- TABLE 11: Validation (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
- TABLE 12: Validation (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
- TABLE 13: Diagnostic (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
- TABLE 14: Diagnostic (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
- TABLE 15: Diagnostic (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
- TABLE 16: Drug Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 17: Drug Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
- TABLE 18: Drug Development (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
- TABLE 19: Personalized Medicine (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
- TABLE 20: Personalized Medicine (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
- TABLE 21: Personalized Medicine (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
- TABLE 22: Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
- TABLE 23: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
- TABLE 24: Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
- TABLE 25: Cancer (Disease) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 26: Cancer (Disease) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
- TABLE 27: Cancer (Disease) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
- TABLE 28: Cardiovascular Diseases (Disease) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
- TABLE 29: Cardiovascular Diseases (Disease) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
- TABLE 30: Cardiovascular Diseases (Disease) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
- TABLE 31: Neurological Diseases (Disease) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
- TABLE 32: Neurological Diseases (Disease) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
- TABLE 33: Neurological Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
- TABLE 34: Immunological Diseases (Disease) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
- TABLE 35: Immunological Diseases (Disease) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
- TABLE 36: Immunological Diseases (Disease) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
- TABLE 37: Other Diseases (Disease) World Market by Region/Country in US$ Million: 2020 to 2027
- TABLE 38: Other Diseases (Disease) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
- TABLE 39: Other Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
- GEOGRAPHIC MARKET ANALYSIS
- UNITED STATES
- Market Facts & Figures
- US Biomarkers Market Share (in %) by Company: 2019 & 2025
- Market Analytics
- TABLE 40: United States Biomarkers Market Estimates and Projections in US$ Million by Type: 2020 to 2027
- TABLE 41: Biomarkers Market in the United States by Type: A Historic Review in US$ Million for 2012-2019
- TABLE 42: United States Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 43: United States Biomarkers Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
- TABLE 44: Biomarkers Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
- TABLE 45: Biomarkers Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
- TABLE 46: United States Biomarkers Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
- TABLE 47: Biomarkers Market in the United States by Disease: A Historic Review in US$ Million for 2012-2019
- TABLE 48: United States Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- CANADA
- TABLE 49: Canadian Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
- TABLE 50: Canadian Biomarkers Historic Market Review by Type in US$ Million: 2012-2019
- TABLE 51: Biomarkers Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
- TABLE 52: Canadian Biomarkers Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
- TABLE 53: Biomarkers Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
- TABLE 54: Canadian Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 55: Canadian Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
- TABLE 56: Canadian Biomarkers Historic Market Review by Disease in US$ Million: 2012-2019
- TABLE 57: Biomarkers Market in Canada: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
- JAPAN
- TABLE 58: Japanese Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
- TABLE 59: Biomarkers Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
- TABLE 60: Japanese Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 61: Japanese Demand Estimates and Forecasts for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 62: Japanese Biomarkers Market in US$ Million by Application: 2012-2019
- TABLE 63: Biomarkers Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
- TABLE 64: Japanese Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
- TABLE 65: Biomarkers Market in Japan: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
- TABLE 66: Japanese Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- CHINA
- TABLE 67: Chinese Biomarkers Market Growth Prospects in US$ Million by Type for the Period 2020-2027
- TABLE 68: Biomarkers Historic Market Analysis in China in US$ Million by Type: 2012-2019
- TABLE 69: Chinese Biomarkers Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
- TABLE 70: Chinese Demand for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 71: Biomarkers Market Review in China in US$ Million by Application: 2012-2019
- TABLE 72: Chinese Biomarkers Market Share Breakdown by Application: 2012 VS 2020 VS 2027
- TABLE 73: Chinese Biomarkers Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
- TABLE 74: Biomarkers Historic Market Analysis in China in US$ Million by Disease: 2012-2019
- TABLE 75: Chinese Biomarkers Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
- EUROPE
- Market Facts & Figures
- European Biomarkers Market: Competitor Market Share Scenario (in %) for 2019 & 2025
- Market Analytics
- TABLE 76: European Biomarkers Market Demand Scenario in US$ Million by Region/Country: 2020-2027
- TABLE 77: Biomarkers Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
- TABLE 78: European Biomarkers Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
- TABLE 79: European Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020-2027
- TABLE 80: Biomarkers Market in Europe in US$ Million by Type: A Historic Review for the Period 2012-2019
- TABLE 81: European Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 82: European Biomarkers Addressable Market Opportunity in US$ Million by Application: 2020-2027
- TABLE 83: Biomarkers Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
- TABLE 84: European Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 85: European Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
- TABLE 86: Biomarkers Market in Europe in US$ Million by Disease: A Historic Review for the Period 2012-2019
- TABLE 87: European Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- FRANCE
- TABLE 88: Biomarkers Market in France by Type: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 89: French Biomarkers Historic Market Scenario in US$ Million by Type: 2012-2019
- TABLE 90: French Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 91: Biomarkers Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
- TABLE 92: French Biomarkers Historic Market Review in US$ Million by Application: 2012-2019
- TABLE 93: French Biomarkers Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
- TABLE 94: Biomarkers Market in France by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 95: French Biomarkers Historic Market Scenario in US$ Million by Disease: 2012-2019
- TABLE 96: French Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- GERMANY
- TABLE 97: Biomarkers Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 98: German Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 99: German Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 100: Biomarkers Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
- TABLE 101: German Biomarkers Market in Retrospect in US$ Million by Application: 2012-2019
- TABLE 102: Biomarkers Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
- TABLE 103: Biomarkers Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 104: German Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 105: German Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- ITALY
- TABLE 106: Italian Biomarkers Market Growth Prospects in US$ Million by Type for the Period 2020-2027
- TABLE 107: Biomarkers Historic Market Analysis in Italy in US$ Million by Type: 2012-2019
- TABLE 108: Italian Biomarkers Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
- TABLE 109: Italian Demand for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 110: Biomarkers Market Review in Italy in US$ Million by Application: 2012-2019
- TABLE 111: Italian Biomarkers Market Share Breakdown by Application: 2012 VS 2020 VS 2027
- TABLE 112: Italian Biomarkers Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
- TABLE 113: Biomarkers Historic Market Analysis in Italy in US$ Million by Disease: 2012-2019
- TABLE 114: Italian Biomarkers Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
- UNITED KINGDOM
- TABLE 115: United Kingdom Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
- TABLE 116: Biomarkers Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
- TABLE 117: United Kingdom Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 118: United Kingdom Demand Estimates and Forecasts for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 119: United Kingdom Biomarkers Market in US$ Million by Application: 2012-2019
- TABLE 120: Biomarkers Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
- TABLE 121: United Kingdom Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
- TABLE 122: Biomarkers Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
- TABLE 123: United Kingdom Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- SPAIN
- TABLE 124: Spanish Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
- TABLE 125: Spanish Biomarkers Historic Market Review by Type in US$ Million: 2012-2019
- TABLE 126: Biomarkers Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
- TABLE 127: Spanish Biomarkers Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
- TABLE 128: Biomarkers Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
- TABLE 129: Spanish Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 130: Spanish Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
- TABLE 131: Spanish Biomarkers Historic Market Review by Disease in US$ Million: 2012-2019
- TABLE 132: Biomarkers Market in Spain: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
- RUSSIA
- TABLE 133: Russian Biomarkers Market Estimates and Projections in US$ Million by Type: 2020 to 2027
- TABLE 134: Biomarkers Market in Russia by Type: A Historic Review in US$ Million for 2012-2019
- TABLE 135: Russian Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 136: Russian Biomarkers Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
- TABLE 137: Biomarkers Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
- TABLE 138: Biomarkers Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
- TABLE 139: Russian Biomarkers Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
- TABLE 140: Biomarkers Market in Russia by Disease: A Historic Review in US$ Million for 2012-2019
- TABLE 141: Russian Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- REST OF EUROPE
- TABLE 142: Rest of Europe Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020-2027
- TABLE 143: Biomarkers Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012-2019
- TABLE 144: Rest of Europe Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 145: Rest of Europe Biomarkers Addressable Market Opportunity in US$ Million by Application: 2020-2027
- TABLE 146: Biomarkers Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
- TABLE 147: Rest of Europe Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 148: Rest of Europe Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
- TABLE 149: Biomarkers Market in Rest of Europe in US$ Million by Disease: A Historic Review for the Period 2012-2019
- TABLE 150: Rest of Europe Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- ASIA-PACIFIC
- TABLE 151: Asia-Pacific Biomarkers Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 152: Biomarkers Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
- TABLE 153: Asia-Pacific Biomarkers Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
- TABLE 154: Biomarkers Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 155: Asia-Pacific Biomarkers Historic Market Scenario in US$ Million by Type: 2012-2019
- TABLE 156: Asia-Pacific Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 157: Biomarkers Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
- TABLE 158: Asia-Pacific Biomarkers Historic Market Review in US$ Million by Application: 2012-2019
- TABLE 159: Asia-Pacific Biomarkers Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
- TABLE 160: Biomarkers Market in Asia-Pacific by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 161: Asia-Pacific Biomarkers Historic Market Scenario in US$ Million by Disease: 2012-2019
- TABLE 162: Asia-Pacific Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- AUSTRALIA
- TABLE 163: Biomarkers Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 164: Australian Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 165: Australian Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 166: Biomarkers Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
- TABLE 167: Australian Biomarkers Market in Retrospect in US$ Million by Application: 2012-2019
- TABLE 168: Biomarkers Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
- TABLE 169: Biomarkers Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 170: Australian Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 171: Australian Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- INDIA
- TABLE 172: Indian Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
- TABLE 173: Indian Biomarkers Historic Market Review by Type in US$ Million: 2012-2019
- TABLE 174: Biomarkers Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
- TABLE 175: Indian Biomarkers Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
- TABLE 176: Biomarkers Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
- TABLE 177: Indian Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 178: Indian Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
- TABLE 179: Indian Biomarkers Historic Market Review by Disease in US$ Million: 2012-2019
- TABLE 180: Biomarkers Market in India: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
- SOUTH KOREA
- TABLE 181: Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 182: South Korean Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 183: Biomarkers Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027
- TABLE 184: Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
- TABLE 185: South Korean Biomarkers Historic Market Analysis in US$ Million by Application: 2012-2019
- TABLE 186: Biomarkers Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
- TABLE 187: Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 188: South Korean Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 189: Biomarkers Market Share Distribution in South Korea by Disease: 2012 VS 2020 VS 2027
- REST OF ASIA-PACIFIC
- TABLE 190: Rest of Asia-Pacific Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
- TABLE 191: Biomarkers Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
- TABLE 192: Rest of Asia-Pacific Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 193: Rest of Asia-Pacific Demand Estimates and Forecasts for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 194: Rest of Asia-Pacific Biomarkers Market in US$ Million by Application: 2012-2019
- TABLE 195: Biomarkers Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
- TABLE 196: Rest of Asia-Pacific Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
- TABLE 197: Biomarkers Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
- TABLE 198: Rest of Asia-Pacific Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- LATIN AMERICA
- TABLE 199: Latin American Biomarkers Market Trends by Region/Country in US$ Million: 2020-2027
- TABLE 200: Biomarkers Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
- TABLE 201: Latin American Biomarkers Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
- TABLE 202: Latin American Biomarkers Market Growth Prospects in US$ Million by Type for the Period 2020-2027
- TABLE 203: Biomarkers Historic Market Analysis in Latin America in US$ Million by Type: 2012-2019
- TABLE 204: Latin American Biomarkers Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
- TABLE 205: Latin American Demand for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 206: Biomarkers Market Review in Latin America in US$ Million by Application: 2012-2019
- TABLE 207: Latin American Biomarkers Market Share Breakdown by Application: 2012 VS 2020 VS 2027
- TABLE 208: Latin American Biomarkers Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
- TABLE 209: Biomarkers Historic Market Analysis in Latin America in US$ Million by Disease: 2012-2019
- TABLE 210: Latin American Biomarkers Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
- ARGENTINA
- TABLE 211: Argentinean Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020-2027
- TABLE 212: Biomarkers Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012-2019
- TABLE 213: Argentinean Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 214: Argentinean Biomarkers Addressable Market Opportunity in US$ Million by Application: 2020-2027
- TABLE 215: Biomarkers Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
- TABLE 216: Argentinean Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 217: Argentinean Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
- TABLE 218: Biomarkers Market in Argentina in US$ Million by Disease: A Historic Review for the Period 2012-2019
- TABLE 219: Argentinean Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- BRAZIL
- TABLE 220: Biomarkers Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 221: Brazilian Biomarkers Historic Market Scenario in US$ Million by Type: 2012-2019
- TABLE 222: Brazilian Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 223: Biomarkers Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
- TABLE 224: Brazilian Biomarkers Historic Market Review in US$ Million by Application: 2012-2019
- TABLE 225: Brazilian Biomarkers Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
- TABLE 226: Biomarkers Market in Brazil by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
- TABLE 227: Brazilian Biomarkers Historic Market Scenario in US$ Million by Disease: 2012-2019
- TABLE 228: Brazilian Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- MEXICO
- TABLE 229: Biomarkers Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 230: Mexican Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 231: Mexican Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 232: Biomarkers Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
- TABLE 233: Mexican Biomarkers Market in Retrospect in US$ Million by Application: 2012-2019
- TABLE 234: Biomarkers Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
- TABLE 235: Biomarkers Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 236: Mexican Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 237: Mexican Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- REST OF LATIN AMERICA
- TABLE 238: Rest of Latin America Biomarkers Market Estimates and Projections in US$ Million by Type: 2020 to 2027
- TABLE 239: Biomarkers Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012-2019
- TABLE 240: Rest of Latin America Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 241: Rest of Latin America Biomarkers Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
- TABLE 242: Biomarkers Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
- TABLE 243: Biomarkers Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
- TABLE 244: Rest of Latin America Biomarkers Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
- TABLE 245: Biomarkers Market in Rest of Latin America by Disease: A Historic Review in US$ Million for 2012-2019
- TABLE 246: Rest of Latin America Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- MIDDLE EAST
- TABLE 247: The Middle East Biomarkers Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
- TABLE 248: Biomarkers Market in the Middle East by Region/Country in US$ Million: 2012-2019
- TABLE 249: The Middle East Biomarkers Market Share Breakdown by Region/Country: 2012, 2020, and 2027
- TABLE 250: The Middle East Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
- TABLE 251: The Middle East Biomarkers Historic Market by Type in US$ Million: 2012-2019
- TABLE 252: Biomarkers Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027
- TABLE 253: The Middle East Biomarkers Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
- TABLE 254: Biomarkers Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
- TABLE 255: The Middle East Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 256: The Middle East Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
- TABLE 257: The Middle East Biomarkers Historic Market by Disease in US$ Million: 2012-2019
- TABLE 258: Biomarkers Market in the Middle East: Percentage Share Breakdown of Sales by Disease for 2012,2020, and 2027
- IRAN
- TABLE 259: Iranian Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
- TABLE 260: Biomarkers Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
- TABLE 261: Iranian Biomarkers Market Share Analysis by Type: 2012 VS 2020 VS 2027
- TABLE 262: Iranian Demand Estimates and Forecasts for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 263: Iranian Biomarkers Market in US$ Million by Application: 2012-2019
- TABLE 264: Biomarkers Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
- TABLE 265: Iranian Market for Biomarkers: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
- TABLE 266: Biomarkers Market in Iran: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
- TABLE 267: Iranian Biomarkers Market Share Analysis by Disease: 2012 VS 2020 VS 2027
- ISRAEL
- TABLE 268: Israeli Biomarkers Market Estimates and Forecasts in US$ Million by Type: 2020-2027
- TABLE 269: Biomarkers Market in Israel in US$ Million by Type: A Historic Review for the Period 2012-2019
- TABLE 270: Israeli Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 271: Israeli Biomarkers Addressable Market Opportunity in US$ Million by Application: 2020-2027
- TABLE 272: Biomarkers Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
- TABLE 273: Israeli Biomarkers Market Share Analysis by Application: 2012 VS 2020 VS 2027
- TABLE 274: Israeli Biomarkers Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
- TABLE 275: Biomarkers Market in Israel in US$ Million by Disease: A Historic Review for the Period 2012-2019
- TABLE 276: Israeli Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- SAUDI ARABIA
- TABLE 277: Saudi Arabian Biomarkers Market Growth Prospects in US$ Million by Type for the Period 2020-2027
- TABLE 278: Biomarkers Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012-2019
- TABLE 279: Saudi Arabian Biomarkers Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
- TABLE 280: Saudi Arabian Demand for Biomarkers in US$ Million by Application: 2020 to 2027
- TABLE 281: Biomarkers Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
- TABLE 282: Saudi Arabian Biomarkers Market Share Breakdown by Application: 2012 VS 2020 VS 2027
- TABLE 283: Saudi Arabian Biomarkers Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
- TABLE 284: Biomarkers Historic Market Analysis in Saudi Arabia in US$ Million by Disease: 2012-2019
- TABLE 285: Saudi Arabian Biomarkers Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
- UNITED ARAB EMIRATES
- TABLE 286: Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 287: United Arab Emirates Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 288: Biomarkers Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027
- TABLE 289: Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
- TABLE 290: United Arab Emirates Biomarkers Historic Market Analysis in US$ Million by Application: 2012-2019
- TABLE 291: Biomarkers Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
- TABLE 292: Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 293: United Arab Emirates Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 294: Biomarkers Market Share Distribution in United Arab Emirates by Disease: 2012 VS 2020 VS 2027
- REST OF MIDDLE EAST
- TABLE 295: Biomarkers Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
- TABLE 296: Rest of Middle East Biomarkers Historic Market Analysis in US$ Million by Type: 2012-2019
- TABLE 297: Rest of Middle East Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 298: Biomarkers Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
- TABLE 299: Rest of Middle East Biomarkers Market in Retrospect in US$ Million by Application: 2012-2019
- TABLE 300: Biomarkers Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
- TABLE 301: Biomarkers Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
- TABLE 302: Rest of Middle East Biomarkers Historic Market Analysis in US$ Million by Disease: 2012-2019
- TABLE 303: Rest of Middle East Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
- AFRICA
- TABLE 304: African Biomarkers Market Estimates and Projections in US$ Million by Type: 2020 to 2027
- TABLE 305: Biomarkers Market in Africa by Type: A Historic Review in US$ Million for 2012-2019
- TABLE 306: African Biomarkers Market Share Breakdown by Type: 2012 VS 2020 VS 2027
- TABLE 307: African Biomarkers Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
- TABLE 308: Biomarkers Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
- TABLE 309: Biomarkers Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
- TABLE 310: African Biomarkers Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
- TABLE 311: Biomarkers Market in Africa by Disease: A Historic Review in US$ Million for 2012-2019
- TABLE 312: African Biomarkers Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
IV. COMPETITION
- Total Companies Profiled: 204
